Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam

Vasa - Journal of Vascular Diseases

Volumn 39, Issue 2, 2010, Pages 169-174

  Reich Schupke, Stefanie ^a   Weyer, K ^a   Altmeyer, P ^a   Stucker M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Foam; Polidocanol; Sclerotherapy; Tributaries; Varicosis

Indexed keywords

POLIDOCANOL;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FOAM SCLEROTHERAPY; FOLLOW UP; HEADACHE; HUMAN; HYPERPIGMENTATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; MIGRAINE; NECROSIS; PAIN; PARESTHESIA; PROFESSIONAL KNOWLEDGE; SCLEROTHERAPY; SKIN INDURATION; THERAPY EFFECT; THROMBOPHLEBITIS; VARICOSIS; VEIN THROMBOSIS; VISUAL DISORDER;

AGED; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; RETROSPECTIVE STUDIES; SCLEROSING SOLUTIONS; SCLEROTHERAPY; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VARICOSE VEINS;

EID: 77952517844     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000023     Document Type: Article

References (18)

1. Alos J, Carreno P, Lopez JA, Estadella B, Serra-Prat M, Marinello J. Efficacy and safety of sclerotherapy using Polidocanol foam: A controlled clinical trial. Eur J Vasc Endovasc Surg 2006; 31: 101-107 (Pubitemid 43024991)
2. Breu FX, Guggenbichler S, Wollmann JC. 2nd European Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa 2008; S71: 3-29.
3. Breu FX, Guggenbichler S, Wollmann J C. Duplex ultrasound and efficacy criteria in foam sclerotherapy from the 2ndEuropean Consensus Meeting on Foam Sclerotherapy 2006, Tegernsee, Germany. Vasa 2008; 1: 90-154
4. Caggiati A, Bergan JJ, Gloviczki P, Jantet G, Wendell-Smith CP, Partsch H. Nomenclature of the veins of the lower limbs: An international interdisciplinary consensus statement. J Vasc Surg 2002; 36: 416-422 (Pubitemid 35014985)
5. Cavezzi A, Frullini A, Ricci S, Tessari L. Treatment of varicose veins by foam sclerotherapy: two clinical series. Phlebology 2002; 17: 13-18 (Pubitemid 35231053)
6. Coleridge-Smith PD. A personal method for foam sclerotherapy: techniques and results. In: Bergan J, Cheng VL (Edts): Foam Sclerotherapy - a textbook. Royal Society of Medicine Press Ltd. 2008, p69-77.
7. Conrad P, Malouf GN, Stacey MC. The Australian polidocanol (aethoxysclerol) study. Results at 2 years. Dermatol Surg 1995; 21: 334-336
8. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, KIstner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Coleridge Smith P, Wakefield TW for the American Venous Forum International Ad Hoc Committee for Revision of the CEAP-Classification. J Vasc Surg 2004; 40: 1248-1252
9. Hach W, Gruß JD, Hach-Wunderle V, Jünger M. VenenChirurgie: Leitfaden für Gefäßchirurgen, Angiologen, Dermatologen und Phlebologen. Schattauer-Verlag 2007.
10. Hamel-Desnos C, Desnos P, Wollmann JC, Ouvry P, Mako S, Allaert FA. Evaluation of the efficacy of Polidocanol in the form of foam compared with liquid form in sclerotherapy of the long saphenous vein: Initial results. Dermatol Surg 2003; 29: 1170-1175 (Pubitemid 38009913)
11. Hamel-Desnos C, Ouvry P, Benigni JP, Boitelle G, Schadeck M, Desnos P, Allaert A. Comparison of 1 % and 3 % Polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2-year-follow-up: "The 3 / 1 Study" Eur J Vasc Endovasc Surg 2007; 34: 723-729
12. Jia X, Mowatt G, Burr JM, Cassar K, Cook J, Fraser C. Systemic review of foam sclerotherapy for varicose veins. Br J Surg 2007; 94: 925-936 (Pubitemid 47236534)
13. Kern P, Ramelet AA, Wütschert R, Hayoz D. Compression after sclerotherapy for teleangiectasias and reticular veins: a randomized controlled trial. J Vasc Surg 2007; 45: 1212-1216 (Pubitemid 46817846)
14. Noppeney T, Noppeney J, Kurth I. Results after standard varicose vein surgery. Zentralbl Chir 2002; 127: 748-751
15. Rabe E, Otto J, Schliephake D, Pannier F. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): A randomised controlled multicentre clinical trial. Eur J Vasc Endovasc Surg 2008; 35: 238-245 (Pubitemid 351163086)
16. Schultz-Ehrenburg U, Reich-Schupke S, Robak-Pawelczyk B, Rudolph T, Moll C, Weindorf N, Hirche H, Altmeyer P, Stücker M. Prospective epidemiological study on the beginning of varicose veins. Phlebologie 2009; 38: 17-25.
17. Stücker M, Kobus S, Altmeyer P, Reich-Schupke S. Review of published information on foam sclerotherapy. Derm Surg 2010 (in press).
18. Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27: 58-60. (Pubitemid 32107620)